Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim after DCEP for PBSC mobilization in transplant-eligible multiple myeloma
2008-000103-29Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pegfilgrastim in multiple myeloma (MM), sponsored by IRCCS San Matteo Foundation. Started Feb 2008; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2008-000103-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000103-29.